Safety and efficacy outcomes of long-term treatment up to 4 years with 5 lidocaine medicated plaster in patients with post-herpetic neuralgia

Current Medical Research and Opinion

Volumn 28, Issue 8, 2012, Pages 1337-1346

  Sabatowski, Rainer ^a   Hans, Guy ^b   Tacken, Ingrid ^c   Kapanadze, Sofia ^c   Buchheister, Bettina ^c   Baron, Ralf ^d  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c GRÜNENTHAL GMBH   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

5 lidocaine medicated plaster; Drug therapy; Follow up study; Lidocaine therapeutic use adverse effects; Long term treatment; Neuralgia; Post herpetic

Indexed keywords

ANALGESIC AGENT; LIDOCAINE;

ADULT; AGED; ALLODYNIA; ANALGESIA; APPLICATION SITE PRURITUS; ARTICLE; BACKACHE; BANDAGES AND DRESSINGS; BRONCHITIS; CLINICAL EFFECTIVENESS; CLINICAL EXAMINATION; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; CONTROLLED STUDY; DERMATITIS; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSGEUSIA; ERYTHEMA; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; GLIOBLASTOMA; GLUCOSE BLOOD LEVEL; HEARING IMPAIRMENT; HEART FAILURE; HEART INFARCTION; HERPES ZOSTER; HUMAN; HYPERTENSION; ISCHIALGIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICATED PLASTER; MULTIPLE ORGAN FAILURE; MYALGIA; NEUROPATHIC PAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PANCYTOPENIA; PARESTHESIA; PATIENT MONITORING; PHYSICIAN; PNEUMONIA; POSTHERPETIC NEURALGIA; RASH; RATING SCALE; RESPIRATORY FAILURE; RHINOPHARYNGITIS; SIDE EFFECT; SKIN EXAMINATION; SKIN IRRITATION; TACHYCARDIA; TINNITUS; TREATMENT DURATION; URINARY TRACT INFECTION; URTICARIA;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; ANESTHETICS, LOCAL; CASTS, SURGICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864544037     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.707977     Document Type: Article

References (26)

1. Watson CP, Oaklander AL. Postherpetic neuralgia. Pain Pract 2002;2:295-307
2. Gialloreti L, Merito M, Pezzotti P, et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, populationbased study. BMC Infect Dis 2010;10:230
3. Johnson RW, McElhaney J. Postherpetic neuralgia in the elderly. Int J Clin Pract 2009;63:1386-91
4. Weinke T, Edte A, Schmitt S, Lukas K. Impact of herpes zoster and postherpetic neuralgia on patients' quality of life: A patient-reported outcomes survey. Z Gesundh Wiss 2010;18:367-74
5. Baron R, Mayoral V, Leijon G, et al. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. Clin Drug Investig 2009;29:231-41
6. Binder A, Bruxelle J, Rogers P, et al. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial. Clin Drug Investig 2009;29:393-408
7. Hans G, Sabatowski R, Binder A, et al. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study. Curr Med Res Opin 2009;25:1295-305
8. Katz N, Gammaitoni A, Davis M, Dworkin R. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: An effectiveness trial. Pain Med 2002;3:324-32
9. Kern K, Kohl M, Kiefer RT. Lidocain-Pflaster zur Therapie neuropathischer und nichtneuropathischer Schmerzen. Klinische Fallstudie an 87 Patienten. Nervenarzt 2010;81:1490-7
10. Lin P, Fan S, Huang C, et al. Analgesic effect of lidocaine patch 5% in the treatment of acute herpes zoster: A double-blind and vehicle-controlled study. Reg Anesth Pain Med 2008;33:320-5
11. Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: A randomized, double-blind, placebo-controlled study. Pain 2003;106:151-8
12. Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39-44
13. Krumova E, Zeller M, Westermann A, Maier C. Lidocaine patch (5%) produces a selective, but incomplete block of Adelta and C fibers. Pain 2012;153:273-80
14. Wolff RF, Bala MM, Westwood M, et al. 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): A systematic review. Acta Neurol Scand 2011;123:295-309
15. Dworkin R, O'Connor A, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: An overview and literature update. Mayo Clin Proc 2010;85:S3-14
16. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010;17: 1113-e88
17. Finnerup N, Sindrup S, Jensen T. Recent advances in pharmacological treatment of neuropathic pain. F1000 Med Rep 2010;2:52
18. Edwards IR, Biriell C. Harmonisation in pharmacovigilance. Drug Saf 1994;10:93-102
19. Grzanka A, Misiolek H, Filipowska A, et al. Adverse effects of local anaesthetics-allergy, toxic reactions or hypersensitivity. Anestezjol Intens Ter 2010;42:175-8
20. Versatis 5% Medicated Plaster-Summary of Product Characteristics (SPC)-electronic Medicines Compendium (eMC). Available at: http://www. medicines.org.uk/emc/medicine/19291 Last accessed 24 April 2012
21. Kallio H, Niskanen ML, Havia M, et al. I.V. ropivacaine compared with lidocaine for the treatment of tinnitus. Br J Anaesth 2008;101:261-5
22. Jurgens G, Graudal N, Kampmann J. Therapeutic drug monitoring of antiarrhythmic drugs. Clin Pharmacokinet 2003;42:647-63
23. Rehm S, Binder A, Baron R. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study. Curr Med Res Opin 2010;26:1607-19
24. Garnock-Jones K, Keating G. Lidocaine 5% medicated plaster: A review of its use in postherpetic neuralgia. Drugs 2009;69:2149-65
25. Galer B, Gammaitoni A. More than 7 years of consistent neuropathic pain relief in geriatric patients. Arch Intern Med 2003;163:628
26. Wilhelm I, Tzabazis A, Likar R, et al. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster. Eur J Anaesthesiol 2011; 27:169-73